Lamisilate

Terbinafine Hydrochloride, the active ingredient in Lamisilate, is an allylamine antifungal presented as a topical formulation for skin use. It treats superficial fungal infections—including tinea pedis, tinea corporis, tinea cruris and tinea versicolor—and are commonly encountered in clinical practice.

GNH USA supplies Lamisilate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and other markets. We adhere to stringent manufacturing standards and provide reliable supply chain support for healthcare providers.

Terbinafine Hydrochloride is an allylamine antifungal used to treat superficial dermatophyte infections.

- Tinea pedis: reduces itching and clears fungal infection of the feet. - Tinea corporis: eliminates ring‑shaped lesions on the body. - Tinea cruris: resolves jock‑itch and clears fungal growth in the groin area. - Tinea versicolor: normalizes skin pigmentation by eradicating yeast overgrowth.

Terbinafine Hydrochloride may cause local skin reactions when applied topically.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or flaking of the skin. - Mild irritation or stinging. - Contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Extensive blistering or skin necrosis. - Systemic hypersensitivity with fever. - Rare hepatic toxicity. - Unexplained swelling of the face or throat.

Before using Lamisilate, consider the following precautions: - Assess for hypersensitivity: avoid use in patients with known allergy to terbinafine or related compounds. - Evaluate skin integrity: do not apply on open wounds or severely damaged skin. - Limit duration: follow prescriber instructions to prevent over‑use. - Monitor for systemic signs: discontinue if severe rash or systemic symptoms develop. - Pediatric use: ensure dosage form is appropriate for children as directed. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Terbinafine topical has limited systemic absorption, but potential interactions should be considered.

Major Interactions (Avoid): - Oral terbinafine: concurrent use may increase systemic exposure. - Strong CYP2D6 inhibitors: could raise terbinafine levels if absorbed. - Other topical antifungals containing the same active ingredient.

Moderate Interactions (Monitor Closely): - Alcohol‑based skin cleansers: may alter drug absorption. - Topical corticosteroids: may reduce antifungal efficacy.